Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mtc 3 mill o/s 2.80 bounce time !
HLBZ $1.74 hod rocket $2 break possible on this news: https://finance.yahoo.com/news/helbiz-media-italian-national-television-133000611.html
PSHG..........CYBN............OBSV............TRVN..........OPTT..........https://stockcharts.com/h-sc/ui?s=OPTT&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=TRVN&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=OBSV&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=CYBN&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=PSHG&p=D&yr=0&mn=2&dy=12&id=p84071410134
$NUTX breakout at $4 ,break
NISN @ .96: Volume, price & online chatter rising. Easy China low float crowd target all week..Heads up.
No, it delists tomorrow per this morning's PR
$MTC got 12000 AVG 2.73
$SMFL waiting for .67 break
$TMBR my #1. 68 million float. Could really move from here IMO.
CLWT still climbing higher, new pre market high
What is bad for RDBX is good for CSSE
They missed the estimate. But it is green now.
They will do a R/S before letting delisting happen, wouldn't you think?
MEGL gonna be interesting , Ran up AH.
Mtc $2.73 bidding here squeeze watch
The Bitcoin shot up immediately
MARA much higher
$TMBR @ .1050..A .21 cent offering dropped to a .12 cents offering …volume yesterday above average at 47 million..pre market volume 2.3 million
And the Market loves it, biggest fear of the market has been eased, great news.
Latest inflation data must have come in under the consensus estimate
Prices that consumers pay for a variety of goods and services rose 8.5% in July from a year ago, a slowing pace from the previous month due largely to a drop in gasoline prices.
On a monthly basis, prices were flat as energy prices broadly declined 4.6% and gasoline fell 7.7%. That offset a 1.1% monthly gain in food prices and a 0.5% increase in shelter costs.
Economists surveyed by Dow Jones were expecting headline CPI to increase 8.7% on an annual basis and 0.2% monthly.
Excluding volatile food and energy prices, so-called core CPI rose 5.9% annually and 0.3% monthly, compared to respective estimates of 6.1% and 0.5%.
Even with the lower-than-expected numbers, inflation pressures remained strong.
The jump in the food index put the 12-month increase to 10.9%, the fastest pace since May 1979. Even wit
HLBZ was $1.33 earlier, $1.60
Not bad
$ODYY NEWS OUT !!!!
Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion
Las Vegas, NV, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-improving medical products, today announces the completion and safety findings from Cohort I of its Multi-Day Ascending Dosing (MAD) arm for its Phase I Clinical Trial. Odyssey’s trial is administering PRV-002, its novel drug to treat concussion, to healthy human subjects. MAD Cohort I subjects were dosed for five consecutive days. The drug, PRV-002 was safe and well tolerated in this cohort.
The trial is being conducted by a leading clinical research organization, Avance Clinical Pty Ltd, through Nucleus Network, a Phase 1 clinical trial provider with multiple sites throughout Australia. Cohort I of MAD included eight healthy human volunteers that received one low dose of intranasal PRV-002 for five consecutive days followed by evaluations for abnormal responses. No severe adverse events were noted as PRV-002 appeared to be well-tolerated.
Dr. Jacob VanLandingham of Odyssey Health, Inc. commented, “As the head of drug development for the PRV-002 concussion treatment, I was very happy to see these positive safety results when dosing for multiple days. PRV-002 appears to be well-tolerated when given intranasally. If PRV-002 is found to be efficacious for concussed patients in the Phase 2/3 trials, I believe that intranasal brain-targeting will be the key to its success. So far, the intranasal drug/device combination has functioned nicely and has been well-tolerated in the clinical setting.”
Concussions represent an ‘unmet’ medical need. Common settings for concussion include contact sporting events, military training and operations, motor vehicle accidents and elderly assistive-living facilities due to falls.
The Phase I MAD clinical trial is ongoing and consists of a total of 16 healthy subjects. The Phase I Single Ascending Dosing (SAD) arm has successfully been completed and was well-tolerated. Odyssey will report additional MAD results as they become available.
About Odyssey Health Inc. (formerly Odyssey Group International, Inc.)
Odyssey Health Inc. (OTC: ODYY) is a medical company with a focus in the area of life-saving medical solutions. Odyssey's corporate mission is to create, acquire and develop distinct assets, intellectual property, and exceptional technologies that provide meaningful medical solutions. The company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. For more information, visit the company’s website at www.odysseyhealthinc.com
We encourage our shareholders to visit: http://www.odysseyhealthinc.com or Twitter: @OdysseyHealth1.
About PRV-002
PRV-002 is a fully synthetic non-naturally occurring neurosteroid being developed for the treatment of mTBI (concussion). In preclinical studies, PRV-002 has demonstrated equivalent, if not superior, neuroprotective effects compared to related neurosteroids. Animal models of concussion demonstrated that PRV-002 reduces the behavioral pathology associated with brain injury symptoms such as memory impairment, anxiety, and motor/sensory performance. Additionally, PRV-002 is lipophilic and can easily cross the blood-brain barrier to rapidly eliminate swelling, oxidative stress and inflammation in the brain while restoring proper blood flow.
Forward-Looking Statements
This news release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including our ability to continue to raise needed funds, successfully complete the phase I trial, our ability to successfully develop products, rapid changes in our markets, changes in demand for our future products, and legislative, regulatory, competitive developments and general economic conditions.
Inquiries:
Odyssey Health
info@odysseyhealthinc.com
https://www.globenewswire.com/newsroom/ti?nf=ODYxNTkwOSM1MDg1MDU5IzUwMDA4NjI2NA==
https://ml.globenewswire.com/media/YzZhNzFlYWUtNDJiOC00ZWRjLTg2YzgtN2ZmYTdjMTYxMjhhLTUwMDA4NjI2NA==/tiny/Odyssey-Health-Inc.png
Source: Odyssey Health, Inc
© 2022 GlobeNewswire, Inc.
Back to News Headlines
Other Financial Information
Recent News & Disclosure Filings
Recent SEC Filings
Pink Open Market Logo
Pink Current Information
Transfer Agent Verified IconTransfer Agent Verified
Shell Risk IconShell Risk
Independent Directors IconIndependent Directors
Clouded: The US halted Chinese solar-panel imports to enforce a ban on products from Xinjiang because they’re often made with forced labor. As a result, US solar-panel imports could drop by half from last year.
Mtc $2.80 *** 5 red days (3 mill o/s hammer formed reversal watch / squeeze today
CLWT has appeared in the pre market Top 10
Small float
2000 companies report between today to Tuesday the 16 th
SSNT the big gainer since the Schwab platform opened
$TMBR News soon FDA trials, 65 Million float.I Like this play. Priced @ .10c.
looks a lot like a loading wall at $1.60 on AEMD...
Yes Sir made a bit of $ of PSHG. I think it will pull back and consolidate before next leg up. NILE- I think BTC is almost ready for a run in the near term :). MULN-- I think consolidation is basically over, just down from a red day across the board. AYTU--waiting for .22ish. GL
HLBZ 1.56 lod 1.29 short cover 2.39 hod
MEGL, giving me a chuckle. Anything is possible tomorrow morning, starting at 4AM Eastern with the Webull platform.
MTC $2.81-> 3 mill o/s 5 red days hammer formed bullish
GRAY-anyone believes there's more to todays high volume rally(50% up at hod) than simply the Patent news? Like maybe something coming up with the "comprehensive review of strategic options and alternatives" announced in June? This was in the $10+ range a year or so back, a good beaten down lowfloat Bio. Hoping it gets back to 3-4$ area at least.
US climate-bill-will-do-more-harm-than-good
visit - the CoGwriter site - open link with above title wording.
Roblox (RBLX) reported and ate a big one. Earlier headlines last week declared it "way oversold."
VLD very strong earnings report.
Velo3D Announces Sequential Revenue Growth of 60% / Year over Year Growth of More Than 160% for Second Quarter 2022
AEMD 1.70's
HYFM reported. I can't bring myself to read the 10Q.
Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading (Oh, really?) independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (“CEA”), today announced financial results for its second quarter ended June 30, 2022.
SFT and LOTZ will merge, probably to stay alive a while longer until the merged company can figure out a way to get out of the used car business and morph into something else.
Carvana rivals' stocks plunge after earnings
8:27 am ET August 9, 2022 (MarketWatch)
Print
By Jeremy C. Owens
Vroom and CarGurus both disappoint Wall Street a week after Carvana stock shot higher despite weak results
While Carvana Inc. shares soared despite weaker-than-expected financial results last week, two of the online car-seller's smaller rivals were not as fortunate Monday.
CarGurus Inc. (CARG) and Vroom Inc. (VRM) both saw their shares dive in extended trading after issuing quarterly results. CarGurus shares declined 16% in after-hours trading, while Vroom shares fell nearly 10%; Carvana's (CVNA) stock was down about 1%.
All three were among a throng of companies selling used cars online that went public in recent years, just in time for a surge in interest and sales during the COVID-19 pandemic. As the spreading virus kept people away from public transit, and semiconductor shortages combined with other supply-chain difficulties kept car manufacturers from providing new cars, websites selling used cars became more popular.
In year three of the pandemic, though, that dynamic has slowed. Vroom reported that revenue decreased more than 37% to $475.5 million in the second quarter, missing Wall Street's expectations for sales by more than $65 million. While CarGurus revenue more than doubled, that was largely due to a changing business model, as the company seeks to do more business on its platform instead of relying on its legacy business of listing cars available at dealerships.
Carvana missed on both profit and revenue in its report last week, but shares still soared more than 40% higher the next day, for their second-best daily gain ever. CarGurus was the only one of the three companies to beat Wall Street's expectations, posting adjusted earnings of 32 cents a share on sales of $511.2 million against average analyst expectations of 31 cents a share on revenue of $507.3 million, but surprisingly forecast a sequential decline. Executives guided for third-quarter adjusted earnings of 25 cents to 28 cents a share on sales of $460 million to $490 million, while analysts on average were expecting 33 cents a share on sales of $556 million, according to FactSet.
Vroom reported a second-quarter loss of $115.1 million, or 83 cents a share, or 73 cents a share after adjustments related to "realignment" and other costs. That was down from an adjusted loss of 48 cents a share a year ago, and slightly better than the average analyst estimate for an adjusted loss of 75 cents a share, though sales missed the mark.
-Jeremy C. Owens
(END) Dow Jones Newswires
August 09, 2022
3:44 pm ET
*FDA Said Authorized Emergency Use of Jynneos Vaccine (produced by Bavarian Nordic) to Increase Vaccine Supply for Monkeypox; Also Allows for Use of the Vaccine in Individuals Younger Than 18 Years of Age Determined to be at High Risk for Monkeypox Infection
Benzinga
7:45 am ET
SIGA Announces BARDA Exercise Of Procurement Options Valued At ~$26M For IV TPOXX
Benzinga
7:30 am ET
SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX(R)
Followers
|
2550
|
Posters
|
|
Posts (Today)
|
124
|
Posts (Total)
|
661329
|
Created
|
06/03/08
|
Type
|
Free
|
Moderator AugustaFriends | |||
Assistants jobynimble JDUB Mark |
Sign up for Email Updates: http://investorshub.advfn.com/boards/chairmail_sub.asp?board_id=12753
Chart Lessons by IAMGEND - A must learn for all traders
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76625096
Chart tools:
(1) I use http://www.stockcharts.com for charting
(2) For more info on chart formations, see http://www.chartpatterns.com
(3) Chart indicator definitions http://stockcharts.com/education/IndicatorAnalysis/
(4) Explore Level II here-http://www.hotstockmarket.com/forums/showthread.php?t=14938
(5) For a COMPLETE list of indicator meanings http://www.investopedia.com/categories/technicalanalysis.asp
(6) Top insider trades website: http://www.secform4.com/top-lists.htm
BOARD FOR IHUBS HOTTEST CHART PLAYS
http://investorshub.advfn.com/boards/board.aspx?board_id=18372
WHO'S HOT: http://investorshub.advfn.com/boards/hot_people.asp
CHART YOUR STOCKS HERE: http://stockcharts.com/index.html http://www.profitspi.com/
INSTANT TECHNICAL ANALYSIS: http://www.barchart.com/
NEWS FILTER: http://www.marketwatch.com/
GOOD READ: http://www.bloggingstocks.com/
ALL ABOUT TRADERS: http://www.tradersmagazine.com/
TRACK WHAT THE FUNDS ARE DOING - MY FAVORITE SITE!: http://www.mffais.com
COMMENTARY ON EVERYTHING STOCKS: http://www.istockanalyst.com/
BEST ONLINE BROKERAGE:http://www.nobletrading.com/index.php (ask for Efrain)
MARKET MAKERS: http://www.otcbb.com/dynamic/tradingdata/download/mmids.txt
SHORT DATA: http://shortsqueeze.com/
SEC FILINGS: http://www.sec.gov/edgar/searchedgar/companysearch.html
WALL STREET TABLOID: http://dealbreaker.com/
Posts Today
|
124
|
Posts (Total)
|
661329
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |